🌿 SoapBox hemp
US LawReform & ChurchesFlower PricesSeeds & StrainsScienceLawData

Hemp & Cannabinoid Science / Terpene Monographs / Limonene

Limonene

A cyclic monoterpene — not a biphenyl and not a limonoid, contrary to the operator archive. Monoaminergic anti-stress effects documented in rodents; CYP findings are in-vitro and concentration-limited.

At a glance

Structure classmonocyclic monoterpene (p-menthadiene); a cyclohexene ring with an isopropenyl substituent
Molecular formulaC10H16
Molar massabout 136.24 g/mol
Boiling point at 1 atmabout 176 degrees Celsius (349 degrees Fahrenheit)
Vaporization bandabout 165 to 180 degrees Celsius (329 to 356 degrees Fahrenheit)
Enantiomersd-limonene, the (R)-(+) form, smells of orange and is the commercially dominant one; l-limonene, the (S)-(-) form, smells of pine and turpentine
Documented enzyme relationshipmetabolised to carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes; in-vitro inhibition of several CYPs reported at high concentration
Documented behavioural findinglemon-oil vapour anti-stress effect in mice via 5-HT and dopamine modulation
Industrial statushigh-volume citrus-processing byproduct; GRAS flavouring; widely used industrial solvent and degreaser

On this page

CORRECTION to the operator archive: limonene is not biphenyl, and not a limonoid

The 2016 Van Kush terpene notes record limonene as "also called Biphenyl" and suggest that "limonoids are an entire class of cannabinoids", with the entry linking to the Wikipedia article on limonoids. Three separate things need correcting, politely but clearly, because all three are easy mistakes to make from the name alone. First, biphenyl is a completely different compound — two benzene rings joined by a single bond, C12H10, an aromatic used as a heat-transfer fluid and a fungistat. Limonene is C10H16, a monocyclic monoterpene built on the p-menthadiene skeleton: one non-aromatic cyclohexene ring carrying a methyl group and an isopropenyl group. It contains no benzene ring at all, and the two compounds share neither structure, class, odour nor use. Second, limonoids are not limonene relatives: they are highly oxygenated triterpenoid derivatives (C26 and related skeletons) characteristic of the Rutaceae and Meliaceae — limonin in citrus seed, azadirachtin in neem — and they are bitter, non-volatile and structurally remote from limonene. The shared root is the fruit, not the chemistry. Third, limonoids are not a class of cannabinoids and there is no evidence that they act at cannabinoid receptors as a class. The compound on this shelf that genuinely turned out to be a cannabinoid despite not looking like one is beta-caryophyllene, at CB2. Limonene's own documented pharmacology is monoaminergic and metabolic, described below, and it is interesting on its own terms without the limonoid detour.

Sources: marsresident / Van Kush Family (operator) 2016* · Compiled from public compound databases (PubChem 2026* · Gertsch J 2008

Structure and physical constants

Limonene is C10H16 at about 136.24 g/mol, a monocyclic monoterpene with one endocyclic and one exocyclic double bond, boiling at about 176 degrees Celsius at one atmosphere. It is chiral and the two enantiomers are perceptually and commercially distinct: d-limonene, the (R)-(+) form, is the orange-peel compound recovered in enormous volume as a citrus-processing byproduct and used as a flavouring and as a solvent; l-limonene, the (S)-(-) form, smells piney. Most reports and most certificates of analysis give a single combined limonene figure unless a chiral column was used. Limonene autoxidises on air exposure to limonene hydroperoxides and carvone, and those oxidation products — not limonene itself — are the recognised contact sensitisers, which is why a fresh drum and an old drum of the same material have different irritancy profiles. That is a storage and labelling fact of real industrial consequence.

Sources: Compiled from public compound databases (PubChem 2026* · Sun J 2007*

Monoaminergic and behavioural findings contested animal

The clearest behavioural work on limonene comes through citrus-oil vapour studies. Komiya, Takeuchi and Harada reported that lemon-oil vapour produced an anti-stress effect in mice and that the effect was accompanied by modulation of serotonergic and dopaminergic activity, which is the primary-source basis for describing limonene as mood-modulating by a monoaminergic route. do Vale and colleagues, in the Lippia alba chemotype work, reported central effects for limonene alongside citral and myrcene. The operator archive's statement that limonene "can affect mood when smoked or ingested" is broadly consistent with this literature, which is a fairer assessment than the archive usually gets credit for. The frequently repeated claim that limonene acts through adenosine A2A receptors is a different matter: it circulates widely in terpene writing and this shelf could not trace it to a primary source it is willing to assert, so it is recorded here as unverified rather than repeated. The documented monoaminergic finding stands on its own.

Contested — caveat. Rodent inhalation and systemic studies on citrus oil and on isolated limonene; no controlled human mood study is cited here. The adenosine A2A mechanism commonly attributed to limonene could not be traced to a primary source we are prepared to assert, and is flagged as unverified rather than reported as fact.

Sources: Komiya M 2006 · do Vale TG 2002 · marsresident / Van Kush Family (operator) 2016*

Cytochrome P450: what is actually documented contested in vitro

Miyazawa, Shindo and Shimada showed that both limonene enantiomers are metabolised to the corresponding carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. That is a substrate relationship: it says which human enzymes clear limonene, and it is the best-supported P450 fact about the compound. Separately, in-vitro microsomal work has reported weak inhibition of several cytochrome P450 isoforms including CYP2C9 and CYP2D6 by d-limonene. Two cautions apply to that second finding and they are the same cautions that apply to most in-vitro terpene enzymology. The inhibition is reported at concentrations far above the plasma levels achievable from dietary or aromatic exposure, and no clinical drug interaction attributable to limonene has been demonstrated in humans — Sun's safety and clinical-applications review is notable for how well tolerated high oral doses of d-limonene have been in human studies without interaction signals emerging. Anyone reasoning about real interaction risk in this botanical space should go to the CYP450 shelf and start with piperine, where the human data are much stronger.

Contested — caveat. The CYP2C9 and CYP2D6 inhibition findings are in-vitro microsomal results at concentrations above plausible human exposure, and this shelf does not name a specific primary inhibition paper it can verify. No human limonene drug interaction has been demonstrated. Do not use this section as an interaction warning in either direction.

Sources: Miyazawa M 2002 · Sun J 2007*

Where limonene actually is, and at what percent contested

BotanicalReported limonene contentBasisSource
Citrus peel oils (orange, lemon, grapefruit)the dominant constituent, commonly the large majority of cold-pressed peel oilpercent of essential oilSun 2007; reference compilation
Black pepper (Piper nigrum)a leading constituent alongside beta-caryophyllene and the pinenespercent of essential oiloperator archive; reference compilation
Cannabis sativaa common major terpene in many chemovarspercent of terpene fractionBooth and Bohlmann 2019; Russo 2011
Dill, caraway, celery seeda major constituent alongside carvonepercent of essential oilreference compilation
Conifers (l-limonene)present as a minor to moderate constituentpercent of volatile fractionreference compilation
Contested — caveat. Percent-of-oil figures with wide chemotype and processing variation; citrus peel oil composition in particular depends heavily on extraction route.

Sources: Sun J 2007* · Compiled from public compound databases (PubChem 2026* · Booth JK 2019 · Russo EB 2011 · marsresident / Van Kush Family (operator) 2016*

Industry notes

Limonene is the terpene most likely to be in a product for a reason that has nothing to do with pharmacology: it is cheap, it is available in tanker quantity as a citrus byproduct, and it is an excellent nonpolar solvent and degreaser. That has two consequences for this industry. First, a suspiciously high limonene figure in a terpene-added product may reflect the cheapest available bulk terpene rather than a botanical profile. Second, limonene's solvent character is exactly why it should not be treated casually as a flavouring at high loading in any product with plastic contact surfaces — it attacks some polymers. For a lab tech, note the oxidation products: limonene hydroperoxides and carvone appearing on a chromatogram are an age marker.

Sources: Sun J 2007* · Compiled from public compound databases (PubChem 2026*

See also

References

  1. marsresident / Van Kush Family (operator) (2016) Terpenes: cannabis chemistry and natural medicine Steemit post, STEEM era; archived in this repo as knowledge/herbs/terpenes.json. [identifier unverified]
  2. Compiled from public compound databases (PubChem, NIST WebBook) and supplier specification sheets (2026) Physical constants for terpenes and terpenoids: formula, molar mass, atmospheric boiling point Reference compilation; individual values vary between sources and are given as ranges here. [identifier unverified]
  3. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) Beta-caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences of the USA 105(26):9099-9104. doi:10.1073/pnas.0803601105
  4. Sun J (2007) D-limonene: safety and clinical applications Alternative Medicine Review 12(3):259-264. [identifier unverified]
  5. Komiya M, Takeuchi T, Harada E (2006) Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice Behavioural Brain Research 172(2):240-249. doi:10.1016/j.bbr.2006.05.006
  6. do Vale TG, Furtado EC, Santos JG, Viana GSB (2002) Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba Phytomedicine 9(8):709-714. doi:10.1078/094471102321621304
  7. Miyazawa M, Shindo M, Shimada T (2002) Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes Drug Metabolism and Disposition 30(5):602-607. doi:10.1124/dmd.30.5.602
  8. Booth JK, Bohlmann J (2019) Terpenes in Cannabis sativa — from plant genome to humans Plant Science 284:67-72. doi:10.1016/j.plantsci.2019.03.022
  9. Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects British Journal of Pharmacology 163(7):1344-1364. doi:10.1111/j.1476-5381.2011.01238.x

9 references, of which 3 carry no resolved identifier and are marked as such. A DOI is only recorded here when it was resolved against Crossref and the returned title matched the one printed. None was guessed.

Absence is not safety. A substance or a pair that is not in this section was not checked and is not thereby safe. This is a curated mechanism reference built from primary literature and regulatory reference works — not a comprehensive interaction database, and not a substitute for a clinician or a pharmacist.

Posture

Education and harm reduction. Not medical, legal or financial advice. Every factual claim carries a source; contested and single-source claims are marked as such on the page.

The boundary. This section teaches separation, purification, formulation, dosing arithmetic and analytical chemistry with real parameters, because withholding that detail from someone who will proceed anyway is the harm this library exists to prevent. It does not publish preparative routes for converting one cannabinoid into a more intoxicating one; those are described structurally and cited to the literature, without procedures.